dr. G.W. (Gijs) van Haaften

dr. G.W. (Gijs) van Haaften

Associate Professor
dr. G.W. (Gijs) van Haaften
  • Metabolomics



Areas of expertise

The last five years I have established my own research group working on the genetics and biology of orphan diseases with a focus on metabolic disorders. In my vision genetics is the crucial connecting factor between patients, clinicians, diagnostics, translational research and basic research. I believe in highly collaborative science where my broad background allows me to unite the important stakeholders. My background is highly multidisciplinairy, I studied (bio)chemistry, obtained a PhD in model system genetics followed by postdoctoral work in human disease biology. I have led several successful collaborations, uniting clinicians, lab specialists and researchers from within the UMCU, the Hubrecht Institute and elsewhere, leading to the identification of novel genetic causes of human diseases and last author publications in excellent journals such as Nature Genetics, the New England Journal of Medicine and the American Journal of Human Genetics.


Research program / group

My research group works on the genetics and biology of orphan diseases. We use the latest sequencing technology to identify the causal mutations in rare genetic disorders. Subsequently we study the consequences of these mutations in model systems as human cell lines and the zebrafish. For the zebrafish work we collaborate closely with the lab of Jeroen Bakkers at the Hubrecht institute.

I coordinate the CantuTreat consortium under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases. The main goal of the €500.000 grant is to develop a therapeutic approach for Cantu syndrome. The project involves setting up a global patient registry and in silico, in vitro and in vivo testing of sulfonylurea drugs to correct the function of the mutated KATP channel.

  • Identification of the genetic cause of orphan diseases. We combine whole exome sequencing and subsequent functional studies to pinpoint the causal mutations in several congenital disorders.
  • Towards treatment of Cantu syndrome. In 2012 we discovered the genetic cause of Cantu syndrome. This rare genetic disorder, characterized by congenital hypertrichosis, distinctive facial features and cardiac defects, is caused by usually de novo missense mutations in the K-ATP channel subunit ABCC9. Currently we are investigating whether drugs targeting this channel might be beneficial for Cantu patients.
  • Congenital heart disease. In collaboration with several departments within the UMC Utrecht we perform genetic analysis and subsequent functional studies to further understand how we can help children with congenital heart disease in the best possible way.


Group members

Albertien van Eerde (Post doc)
Anukrati Nigam (PhD student)
Christina Stangl (PhD student)
Edith Peters (Technician)
Federico Tessadori (Senior Post doc)
Glen Monroe (Post doc)
Helen Roessler (PhD student)
Joachim Kutzera (Post doc)
Joline Roze (PhD student)
Karen Duran (Senior Technician)
Kirsten Renkema (Assistant prof)
Rozemarijn Snoek (PhD student)
Sanne Savelberg (Technician)


Selected publications

Side Activities

Head of section research genetics
Member of management team department of Genetics
Coordinator of the CantuTreat consortium (ERare 2014)

Fellowship and Awards

NWO Veni fellowship 2010
EMBO long-term fellowship 2006
Best paper (Erfelijke Stofwisselsziekten Nederland, 2015)

Research Output (86)

FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring

Groeneweg Jolijn W, Roze Joline F, Peters Edith D J, Sereno Ferdinando, Brink Anna G J, Paijens Sterre T, Nijman Hans W, van Meurs Hannah S, van Lonkhuijzen Luc R C W, Piek Jurgen M J, Lok Christianne A R, Monroe Glen R, van Haaften Gijs W, Zweemer Ronald P aug 2021, In: Gynecologic Oncology. 162 , p. 413-420 8 p.

Familial Occurrence of Adult Granulosa Cell Tumors:Analysis of Whole-Genome Germline Variants

Roze Joline F, Kutzera Joachim, Koole Wouter, Ausems Margreet G E M, Engelstad Kristi, Piek Jurgen M J, de Kroon Cor D, Verheijen René H M, van Haaften Gijs, Zweemer Ronald P, Monroe Glen R 2 mei 2021, In: Cancers. 13 13 p.

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors

Roze Joline, Sendino Garví Elena, Stelloo Ellen, Stangl Christina, Sereno Ferdinando, Duran Karen, Groeneweg Jolijn, Paijens Sterre, Nijman Hans, van Meurs Hannah, van Lonkhuijzen Luc, Piek Jurgen, Lok Christianne, Jonges Geertruida, Witteveen Petronella, Verheijen René, van Haaften Gijs, Zweemer Ronald, Monroe Glen 1 feb 2021, In: Cancers. 13 , p. 1-18 18 p.

Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup

Roze Joline, Monroe Glen, Kutzera Joachim, Groeneweg Jolijn, Stelloo Ellen, Paijens Sterre, Nijman Hans, Meurs Hannah van, Lonkhuijzen Luc van, Piek Jurgen, Lok Christianne, Jonges Geertruida, Witteveen Petronella, Verheijen René, Haaften Gijs van, Zweemer Ronald 21 mei 2020, In: Cancers. 12 22 p.

A de novo variant in the human HIST1H4J gene causes a syndrome analogous to the HIST1H4C-associated neurodevelopmental disorder

Tessadori Federico, Rehman Atteeq U, Giltay Jacques C, Xia Fan, Streff Haley, Duran Karen, Bakkers Jeroen, Lalani Seema R, van Haaften Gijs mei 2020, In: European Journal of Human Genetics. 28 , p. 674-678 5 p.

Pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency in zebrafish results in fatal seizures and metabolic aberrations

Ciapaite Jolita, Albersen Monique, Savelberg Sanne M C, Bosma Marjolein, Tessadori Federico, Gerrits Johan, Lansu Nico, Zwakenberg Susan, Bakkers Jeroen P W, Zwartkruis Fried J T, van Haaften Gijs, Jans Judith J, Verhoeven-Duif Nanda M 1 mrt 2020, In: Biochimica et Biophysica Acta. Molecular Basis of Disease. 1866 11 p.

Metabolic fingerprinting reveals extensive consequences of GLS hyperactivity

Rumping Lynne, Pras-Raves Mia L, Gerrits Johan, Tang Yuen Fung, Willemsen Marcel A, Houwen Roderick H J, van Haaften Gijs, van Hasselt Peter M, Verhoeven-Duif Nanda M, Jans Judith J M 1 mrt 2020, In: Biochimica et biophysica acta-General subjects. 1864 , p. 1-7

Cantú syndrome:Findings from 74 patients in the International Cantú Syndrome Registry

Grange Dorothy K., Roessler Helen I., McClenaghan Conor, Duran Karen, Shields Kathleen, Remedi Maria S., Knoers Nine V.A.M., Lee Jin Moo, Kirk Edwin P., Scurr Ingrid, Smithson Sarah F., Singh Gautam K., van Haelst Mieke M., Nichols Colin G., van Haaften Gijs 1 dec 2019, In: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 181 , p. 658-681 24 p.

EML1-associated brain overgrowth syndrome with ribbon-like heterotopia

Oegema Renske, McGillivray George, Leventer Richard, Le Moing Anne-Gaëlle, Bahi-Buisson Nadia, Barnicoat Angela, Mandelstam Simone, Francis David, Francis Fiona, Mancini Grazia M S, Savelberg Sanne, van Haaften Gijs, Mankad Kshitij, Lequin Maarten H 11 nov 2019, In: American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 181 , p. 627-637 11 p.

ABCC9-related Intellectual disability Myopathy Syndrome is a KATP channelopathy with loss-of-function mutations in ABCC9

Smeland Marie F, McClenaghan Conor, Roessler Helen I, Savelberg Sanne, Hansen Geir Åsmund Myge, Hjellnes Helene, Arntzen Kjell Arne, Müller Kai Ivar, Dybesland Andreas Rosenberger, Harter Theresa, Sala-Rabanal Monica, Emfinger Chris H, Huang Yan, Singareddy Soma S, Gunn Jamie, Wozniak David F, Kovacs Attila, Massink Maarten, Tessadori Federico, Kamel Sarah M, Bakkers Jeroen, Remedi Maria S, Van Ghelue Marijke, Nichols Colin G, van Haaften Gijs 1 okt 2019, In: Nature Communications. 10

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet